BIOPORTO DIAGNOSTICS A/S
CVR: 18645882
Secondary names: DIAGNOSTICK A/S, ANTIBODYSHOP A/S
Previous names: SCSK 1868 ApS, RØNNEVANGSCENTRET ApS, IDEGO ApS
The financial health of BIOPORTO DIAGNOSTICS A/S is concerning, characterized by consistent losses and negative equity over the past five years. Revenue has shown a gradual increase from 24.25 million DKK in 2021 to 40.29 million DKK in 2025, yet profits remain deeply negative, with a loss of 81.4 million DKK in 2025. The company's equity has deteriorated significantly, falling to -837.6 million DKK, indicating substantial financial strain and potential solvency issues. While revenue growth suggests some operational progress, the persistent losses and declining equity position raise significant concerns about its long-term viability within the research and experimental development sector.
AI-generated summary
Overview
Details
Contact
Purpose
Selskabets formål er at drive forskning, handel, fabrikation og dermed beslægtet virksomhed primært inden for sundhedssektoren.
Location
Financials
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 40.3 mio. | -81.4 mio. | 24.8 mio. | -837.6 mio. | 26 | |
History
Ownership
Management
Directors
Board
Production units (3)
Similar companies
Companies in the same industry and area